Ingevity (STU:IGX) Total Liabilities : €1,839 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Ingevity Total Liabilities?

Ingevity's Total Liabilities for the quarter that ended in Mar. 2024 was €1,839 Mil.

Ingevity's quarterly Total Liabilities declined from Sep. 2023 (€1,919.07 Mil) to Dec. 2023 (€1,826.57 Mil) but then increased from Dec. 2023 (€1,826.57 Mil) to Mar. 2024 (€1,838.80 Mil).

Ingevity's annual Total Liabilities increased from Dec. 2021 (€1,588.75 Mil) to Dec. 2022 (€1,924.06 Mil) but then declined from Dec. 2022 (€1,924.06 Mil) to Dec. 2023 (€1,826.57 Mil).

Ingevity Total Liabilities Historical Data

The historical data trend for Ingevity's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ingevity Total Liabilities Chart

Ingevity Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,449.81

1,391.15

1,588.75

1,924.06

1,826.57

Ingevity Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,911.43	1,951.41	1,919.07	1,826.57	1,838.80

Ingevity Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ingevity's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	332.779	+	(1312.594	+	93.167
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	79.229	+	8.803)
	=	1,827

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2405.566	-	578.994
	=	1,827

Ingevity's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	323.564	+	(1337.404	+	118.588
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	59.248	+	0)
	=	1,839

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2361.548	-	522.744
	=	1,839

Ingevity Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ingevity's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ingevity (STU:IGX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ingevity Corp (STU:IGX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

NGVT:USA IGX:Germany

Address

4920 O'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405

Website

https://www.ingevity.com

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals which find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focusses on automotive carbon products used in automobiles. The Company sells its products worldwide, with special emphasis on North America.

Ingevity (STU:IGX) Headlines

No Headlines